RESULT_COUNT: 177,PAGE_SIZE: 10000,CURRENT_PAGE: 1,TOTAL_PAGES: 1,API_CALL_CREDITS: 1
TICKER,FIGI_TICKER,FIGI,TITLE,PUBLICATION_DATE,URL,SUMMARY
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies Plunges By Half On Allergy Drug Trial&apos;s Failure,2017-10-20 22:17:16 +0000,http://finance.yahoo.com/r/8d8ed4ce-e8d1-349d-99e7-83bd22f6981d/dbv-technologies-plunges-by-half-on-allergy-drug-trials-failure?src=A00220&yptr=yahoo&.tsrc=rss,Shares of DBV Technologies fell after Friday&apos;s close on reports the company&apos;s test of a drug to treat peanut allergies failed.
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies peanut allergy drug fails key study,2017-10-20 20:49:50 +0000,https://finance.yahoo.com/news/dbv-technologies-peanut-allergy-drug-204950031.html?.tsrc=rss,"Drug developer DBV Technologies SA  said on Friday its peanut allergy treatment  did not meet the main goal in a highly anticipated late-stage  study.  The trial, which tested a 250 microgram stick-on patch  called Viaskin Peanut, in 356 children between the ages of 4-11,  missed the main goal of achieving a certain tolerance to peanut  protein.  Preliminary results show 12 months of the treatment resulted  in 35.3 percent of patients achieving a certain tolerance,  versus a higher-than-expected 13.6 percent response from a  placebo group."
DBVT,DBVT:UW,BBG0076D3TP5,"[$$] Aimmune, DBV: Fighting Over More Than Peanuts",2017-10-18 14:54:00 +0000,http://finance.yahoo.com/r/299052b2-d415-3d37-a6cc-2884e6783de3/aimmune-dbv-fighting-over-more-than-peanuts-1508338492?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Credit Suisse  Aimmune Therapeutics announced today it is starting a clinical collaboration with Regeneron Pharmaceuticals and Sanofi to study AR101 in combination with dupilumab in patients with peanut allergies.  Obviously this is all contingent on AR101 succeeding in its pivotal PALISADE trial, where we continue to expect top-line data in first-quarter 2018.  Given the large patient population and key differences in approach between DBV’s PEPITES and Aimmune’s PALISADE trials, we argue the read-through from PEPITES to PALISADE should be relatively limited."
DBVT,DBVT:UW,BBG0076D3TP5,"Editors' Picks Daily: A Detailed Market Outlook, REITs And Buffett",2017-10-18 05:49:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/L1JEExXWaPU/editors-picks-daily-a-detailed-market-outlook-reits-and-buffett-cm861098,By SA Editor Jason Kirsch BySA Editor Jason Kirsch The following summary of our Editors Picks for the previous trading day is a potential new feature that we re currently testing Each article listed below has been selected by our editorial staff as a widely appealing and highly
DBVT,DBVT:UW,BBG0076D3TP5,"Editors' Picks Daily: A Detailed Market Outlook, REITs & Buffett",2017-10-18 01:49:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ea3EteFOrXk/editors-picks-daily-a-detailed-market-outlook-reits-buffett-cm861072,By SA Editor Jason Kirsch BySA Editor Jason Kirsch The following summary of our Editors Picks for the previous trading day is a potential new feature that we re currently testing Each article listed below has been selected by our editorial staff as a widely appealing and highly
DBVT,DBVT:UW,BBG0076D3TP5,Aimmune Therapeutics And DBV Technologies: 2 Different Approaches To Peanut Allergy That Are Likely To Eventually Become Commercially Successful,2017-10-17 13:50:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-dlgSYE_T6Q/aimmune-therapeutics-and-dbv-technologies-2-different-approaches-to-peanut-allergy-that-are-likely-to-eventually-become-commercially-successful-cm860508,By AMP Biotech Research ByAMP Biotech Research Investment Thesis Investment Thesis Investment Thesis Aimmune Therapeutics AIMT and DBV Technologies DBVT are both developing compounds to treat accidental exposure to food allergens Both companies have upcoming pivotal phase
DBVT,DBVT:UW,BBG0076D3TP5,European ADRs Little Changed as Pharma Gains Offset Banking Losses,2017-10-16 15:36:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tTjwXrDPD-w/european-adrs-little-changed-as-pharma-gains-offset-banking-losses-cm860115,American depository receipts of European stocks were 0 03 higher at 140 62 on the Bank of New York Mellon Europe ADR Index on Monday morning American depository receipts of European stocks were 0 03 higher at 140 62 on the Bank of New York Mellon Europe ADR Index on Monday morning Gainers
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies Announces Completion of Blinded Period in REALISE Study of Viaskin Peanut,2017-10-12 05:32:02 +0000,https://finance.yahoo.com/news/dbv-technologies-announces-completion-blinded-053202036.html?.tsrc=rss,"Press Release Montrouge, France, October 12, 2017   DBV Technologies Announces Completion of Blinded Period in REALISE Study of Viaskin Peanut 97.5% of patients continue treatment in the open-label arm ..."
DBVT,DBVT:UW,BBG0076D3TP5,European ADRs Edge Higher in Tuesday Session,2017-10-10 16:30:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EfPWzKImOgE/european-adrs-edge-higher-in-tuesday-session-cm857634,American depository shares of European stocks were trading 0 6 higher at 139 88 on the Bank of New York Mellon Europe ADR index on Tuesday morning American depository shares of European stocks were trading 0 6 higher at 139 88 on the Bank of New York Mellon Europe ADR index on Tuesday
DBVT,DBVT:UW,BBG0076D3TP5,Riding High: DBV Technologies,2017-10-09 06:22:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aUvxt-1O_20/riding-high-dbv-technologies-20171009-00218,Riding High: DBV Technologies
DBVT,DBVT:UW,BBG0076D3TP5,"Relative Strength Alert For DBV Technologies, Boulogne-Billancourt",2017-09-26 22:52:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KIasayUM-1c/relative-strength-alert-for-dbv-technologies-boulogne-billancourt-cm851402,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
DBVT,DBVT:UW,BBG0076D3TP5,European ADRs Edge Lower as Pharmaceutical Stocks See Mixed Fortunes,2017-09-26 15:31:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ohn7hOXtzF0/european-adrs-edge-lower-as-pharmaceutical-stocks-see-mixed-fortunes-cm851118,American depository receipts of European stocks were 0 4 lower at 137 62 on the Bank of New York Mellon Europe ADR Index on Tuesday morning American depository receipts of European stocks were 0 4 lower at 137 62 on the Bank of New York Mellon Europe ADR Index on Tuesday morning Decliners
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies to Attend Upcoming Investor Conferences,2017-09-01 05:32:01 +0000,https://finance.yahoo.com/news/dbv-technologies-attend-upcoming-investor-053201748.html?.tsrc=rss,"Press Release Montrouge, France, September 1, 2017 DBV Technologies to Attend Upcoming Investor Conferences DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today announced ..."
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies Announces Completion of Enrollment in Phase III Extension Study of Viaskin Peanut,2017-08-29 05:32:02 +0000,https://finance.yahoo.com/news/dbv-technologies-announces-completion-enrollment-053202790.html?.tsrc=rss,"Press Release Montrouge, France, August 29, 2017 DBV Technologies Announces Completion of Enrollment in Phase III Extension Study of Viaskin Peanut 93% of patients completing PEPITES opted to enroll in ..."
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies : Monthly information regarding the total number of voting rights and total number of shares of the Company,2017-08-25 09:04:01 +0000,https://finance.yahoo.com/news/dbv-technologies-monthly-information-regarding-090401322.html?.tsrc=rss,                                                          Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations ...
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies : Monthly information regarding the total number of voting rights and total number of shares of the Company,2017-08-22 16:38:01 +0000,https://finance.yahoo.com/news/dbv-technologies-monthly-information-regarding-163801139.html?.tsrc=rss,                               Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations of the Autorité des Marchés ...
DBVT,DBVT:UW,BBG0076D3TP5,European ADRs Edge Lower as Banks Retreat,2017-08-10 15:14:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mADCsfNzocg/european-adrs-edge-lower-as-banks-retreat-cm830230,American depository receipts of European stocks were 1 3 lower at 134 72 on the Bank of New York Mellon Europe ADR Index on Thursday morning American depository receipts of European stocks were 1 3 lower at 134 72 on the Bank of New York Mellon Europe ADR Index on Thursday morning Decliners
DBVT,DBVT:UW,BBG0076D3TP5,"European ADRs Edge Lower as Miners, Pharma Stocks See Mixed Fortunes",2017-08-09 15:35:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DUzMNggi_bI/european-adrs-edge-lower-as-miners-pharma-stocks-see-mixed-fortunes-cm829479,American depository receipts of European stocks were 0 6 lower at 136 14 on the Bank of New York Mellon Europe ADR Index on Wednesday morning American depository receipts of European stocks were 0 6 lower at 136 14 on the Bank of New York Mellon Europe ADR Index on Wednesday morning Decliners
DBVT,DBVT:UW,BBG0076D3TP5,European ADRs Edge Lower as Pharma Stocks See Mixed Fortunes,2017-08-08 15:36:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/v0rK5raW51w/european-adrs-edge-lower-as-pharma-stocks-see-mixed-fortunes-cm828798,American depository receipts of European stocks were 0 09 lower at 137 64 on the Bank of New York Mellon Europe ADR Index on Tuesday morning American depository receipts of European stocks were 0 09 lower at 137 64 on the Bank of New York Mellon Europe ADR Index on Tuesday morning Decliners
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies Initiates Phase III Study of Viaskin Peanut in Peanut-Allergic Patients One to Three Years of Age,2017-08-02 05:32:01 +0000,https://finance.yahoo.com/news/dbv-technologies-initiates-phase-iii-053201054.html?.tsrc=rss,"  Press Release   Montrouge, France,August 2, 2017 DBV Technologies Initiates Phase III Study of Viaskin Peanut in Peanut-Allergic Patients One to Three Years of Age Expansion of clinical program into ..."
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies Reports First Half 2017 Financial Results,2017-07-28 05:32:04 +0000,https://finance.yahoo.com/news/dbv-technologies-reports-first-half-053204446.html?.tsrc=rss,"Press Release Montrouge, France, July 28, 2017 DBV Technologies Reports First Half 2017 Financial Results DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today reported ..."
DBVT,DBVT:UW,BBG0076D3TP5,European ADRs Move Higher in Thursday Trading,2017-07-20 16:22:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YPYLnkQYCHU/european-adrs-move-higher-in-thursday-trading-cm818770,American depository receipts of European stocks were trading 0 49 higher at 136 60 on the Bank of New York Mellon Europe ADR Index on Thursday American depository receipts of European stocks were trading 0 49 higher at 136 60 on the Bank of New York Mellon Europe ADR Index on Thursday
DBVT,DBVT:UW,BBG0076D3TP5,European ADRs Move Higher in Wednesday Trading,2017-07-19 15:22:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zNQGngm3Y64/european-adrs-move-higher-in-wednesday-trading-cm818078,American depositary receipts of European stocks were trading 0 12 higher at 135 67 on the Bank of New York Mellon Europe ADR Index on Wednesday American depositary receipts of European stocks were trading 0 12 higher at 135 67 on the Bank of New York Mellon Europe ADR Index on Wednesday
DBVT,DBVT:UW,BBG0076D3TP5,European ADRs Edge Higher as Miners Log Gains,2017-07-14 15:24:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rkH-C4gTRwI/european-adrs-edge-higher-as-miners-log-gains-cm816203,American depositary receipts of European stocks were 0 4 higher at 135 64 on the Bank of New York Mellon Europe ADR Index on Friday morning American depositary receipts of European stocks were 0 4 higher at 135 64 on the Bank of New York Mellon Europe ADR Index on Friday morning Gainers
DBVT,DBVT:UW,BBG0076D3TP5,European ADRs Edge Higher as Pharmaceutical Stocks Advance,2017-07-12 15:45:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3iLIqNK9iQg/european-adrs-edge-higher-as-pharmaceutical-stocks-advance-cm815065,American depository receipts of European stocks were 0 9 higher at 134 65 on the Bank of New York Mellon Europe ADR Index on Wednesday morning American depository receipts of European stocks were 0 9 higher at 134 65 on the Bank of New York Mellon Europe ADR Index on Wednesday morning Gainers
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies (DBVT) Worth a Look: Stock Up 5.7%,2017-07-10 14:51:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Mi6NsypoFGE/dbv-technologies-dbvt-worth-a-look-stock-up-57-cm813733,DBV Technologies S A DBVT was a big mover last session as the company saw its shares rise nearly 6 on the day The move came on solid volume too with far more shares changing hands than in a normal session This breaks the recent trend of the company as the stock is now trading above
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies (DBVT) Worth a Look: Stock Up 5.7%,2017-07-10 12:38:12 +0000,https://finance.yahoo.com/news/dbv-technologies-dbvt-worth-look-123812188.html?.tsrc=rss,"DBV Technologies S.A. (DBVT) was a big mover last session, as the company saw its shares rise nearly 6% on the day."
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies : Monthly information regarding the total number of voting rights and total number of shares of the Company,2017-07-07 10:44:02 +0000,https://finance.yahoo.com/news/dbv-technologies-monthly-information-regarding-104402628.html?.tsrc=rss,                                                    Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations ...
DBVT,DBVT:UW,BBG0076D3TP5,Half-Year Report on the DBV Technologies Liquidity Contract with Natixis,2017-07-05 20:32:02 +0000,https://finance.yahoo.com/news/half-report-dbv-technologies-liquidity-203202099.html?.tsrc=rss,"AMF REGULATED INFORMATION Montrouge, France, July 5, 2017 Half-Year Report on the DBV Technologies Liquidity Contract with Natixis Under the liquidity contract between DBV TECHNOLOGIES and NATIXIS, the ..."
DBVT,DBVT:UW,BBG0076D3TP5,European ADRs Move Higher in Friday Trading,2017-06-23 15:29:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YpPgbxC687c/european-adrs-move-higher-in-friday-trading-cm807475,American depositary receipts of European stocks were trading 0 12 higher at 133 32 on the Bank of New York Mellon Europe ADR Index on Friday American depositary receipts of European stocks were trading 0 12 higher at 133 32 on the Bank of New York Mellon Europe ADR Index on Friday In
DBVT,DBVT:UW,BBG0076D3TP5,European ADRs Edge Higher as Pharma Gains Offset Oil Stocks' Contractions,2017-06-21 16:20:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4fCA00hTjJI/european-adrs-edge-higher-as-pharma-gains-offset-oil-stocks-contractions-cm806312,American depository receipts of European stocks were 0 1 higher at 132 71 on the Bank of New York Mellon Europe ADR Index on Wednesday morning American depository receipts of European stocks were 0 1 higher at 132 71 on the Bank of New York Mellon Europe ADR Index on Wednesday morning Gainers
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies Highlights Poster Presentations on EPIT® at the 2017 EAACI Congress,2017-06-17 06:32:02 +0000,https://finance.yahoo.com/news/dbv-technologies-highlights-poster-presentations-063202275.html?.tsrc=rss,"Press Release Montrouge, France, June 17, 2017 DBV Technologies Highlights Poster Presentations on EPIT ® at the 2017 EAACI Congress DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock ..."
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies Announces Appointment of Julie O'Neill to Board of Directors,2017-06-15 20:32:01 +0000,https://finance.yahoo.com/news/dbv-technologies-announces-appointment-julie-203201740.html?.tsrc=rss,"Press Release Montrouge, France, June 15, 2017 DBV Technologies Announces Appointment of Julie O`Neill to Board of Directors DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: ..."
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies Announces Results of its 2017 Ordinary and Extraordinary General Meeting,2017-06-15 20:32:01 +0000,https://finance.yahoo.com/news/dbv-technologies-announces-results-2017-203201783.html?.tsrc=rss,"AMF REGULATED INFORMATION Montrouge, France, June 15, 2017 DBV Technologies Announces Results of its 2017 Ordinary and Extraordinary General Meeting Shareholders approve all proposed resolutions DBV Technologies ..."
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies : Monthly information regarding the total number of voting rights and total number of shares of the Company,2017-06-12 09:22:02 +0000,https://finance.yahoo.com/news/dbv-technologies-monthly-information-regarding-092202700.html?.tsrc=rss,                                                        Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations ...
DBVT,DBVT:UW,BBG0076D3TP5,European ADRs Fractionally Higher Despite Banking Contractions,2017-06-01 16:11:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rJwx8SqcsfY/european-adrs-fractionally-higher-despite-banking-contractions-cm797525,American depository receipts of European stocks were 0 1 higher at 135 27 on the Bank of New York Mellon Europe ADR Index on Thursday morning American depository receipts of European stocks were 0 1 higher at 135 27 on the Bank of New York Mellon Europe ADR Index on Thursday morning Gainers
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies to Attend Upcoming Investor Conferences,2017-06-01 05:32:02 +0000,https://finance.yahoo.com/news/dbv-technologies-attend-upcoming-investor-053202227.html?.tsrc=rss,"Press Release Montrouge, France, June 1, 2017 DBV Technologies to Attend Upcoming Investor Conferences DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today announced ..."
DBVT,DBVT:UW,BBG0076D3TP5,"DBV Technologies : Ordinary and Extraordinary General Meeting of June 15, 2017 Procedures for Obtaining Preparatory Documents for the General Meeting",2017-05-24 20:31:01 +0000,https://finance.yahoo.com/news/dbv-technologies-ordinary-extraordinary-general-203101076.html?.tsrc=rss,"AMF REGULATED INFORMATION Montrouge, France, May 24, 2017 Ordinary and Extraordinary General Meeting of June 15, 2017 Procedures for Obtaining Preparatory Documents for the General Meeting DBV Technologies ..."
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies : Monthly information regarding the total number of voting rights and total number of shares of the Company,2017-05-12 08:18:01 +0000,http://finance.yahoo.com/news/dbv-technologies-monthly-information-regarding-081801022.html?.tsrc=rss,Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE ...
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies Highlights Research Presentation of EPIT® for the Treatment of Crohn's Disease at Digestive Disease Week 2017,2017-05-08 05:32:02 +0000,http://finance.yahoo.com/news/dbv-technologies-highlights-research-presentation-053202431.html?.tsrc=rss,"Press Release Montrouge, France, May 8, 2017 DBV Technologies Highlights Research Presentation of EPIT ® for the Treatment of Crohn`s Disease at Digestive Disease Week 2017 DBV Technologies (Euronext: ..."
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies to Attend Upcoming Investor Conferences,2017-05-02 05:32:01 +0000,http://finance.yahoo.com/news/dbv-technologies-attend-upcoming-investor-053201568.html?.tsrc=rss,"Press Release Montrouge, France, May 2, 2017 DBV Technologies to Attend Upcoming Investor Conferences DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today announced that ..."
DBVT,DBVT:UW,BBG0076D3TP5,InPlay from Briefing.com,2017-04-28 07:55:47 +0000,http://finance.yahoo.com/news/inplay-briefing-com-115750752.html?.tsrc=rss,InPlay from Briefing.com
DBVT,DBVT:UW,BBG0076D3TP5,"DBV Technologies Reports March 31, 2017 Cash Position",2017-04-28 05:32:03 +0000,http://finance.yahoo.com/news/dbv-technologies-reports-march-31-053203510.html?.tsrc=rss,"Press Release Montrouge, France, April 28, 2017 DBV Technologies Reports March 31, 2017 Cash Position DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today announced its ..."
DBVT,DBVT:UW,BBG0076D3TP5,European ADRs Move Higher in Tuesday Trading,2017-04-25 16:04:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1EWXF9Ti3bw/european-adrs-move-higher-in-tuesday-trading-cm778747,American depository receipts of European stocks are trading 0 79 higher at 130 16 on the Bank of New York Mellon Europe ADR Index on Tuesday American depository receipts of European stocks are trading 0 79 higher at 130 16 on the Bank of New York Mellon Europe ADR Index on Tuesday In
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies : Monthly information regarding the total number of voting rights and total number of shares of the Company,2017-04-05 14:29:01 +0000,http://finance.yahoo.com/news/dbv-technologies-monthly-information-regarding-142901603.html?.tsrc=rss,                                                               Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations ...
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies to Attend the 10th Kempen Life Sciences Conference,2017-04-05 05:32:02 +0000,http://finance.yahoo.com/news/dbv-technologies-attend-10th-kempen-053202298.html?.tsrc=rss,"   Press Release Montrouge, France, April 5, 2017 DBV Technologies to Attend the 10th Kempen Life Sciences Conference DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today ..."
DBVT,DBVT:UW,BBG0076D3TP5,European ADRs Edge Lower as Telecommunication Stocks Head South,2017-04-03 15:36:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2v-YF-6tGvU/european-adrs-edge-lower-as-telecommunication-stocks-head-south-cm769058,American depository receipts of European stocks were 0 3 lower at 126 69 on the Bank of New York Mellon Europe ADR Index on Monday morning American depository receipts of European stocks were 0 3 lower at 126 69 on the Bank of New York Mellon Europe ADR Index on Monday morning Decliners
DBVT,DBVT:UW,BBG0076D3TP5,4:35 pm DBV Technologies and Geneva University Hospitals announce Phase I Trial results of Viaskin rPT in Pertussis booster vaccination; continue to review data and are evaluating if further development pathways will be explored,2017-03-30 20:35:00 +0000,http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#dbvt,4:35 pm DBV Technologies and Geneva University Hospitals announce Phase I Trial results of Viaskin rPT in Pertussis booster vaccination; continue to review data and are evaluating if further development pathways will be explored
DBVT,DBVT:UW,BBG0076D3TP5,"DBV Technologies, BioNet-Asia and Geneva University Hospitals Announce Phase I Trial Results of Viaskin rPT in Pertussis Booster Vaccination",2017-03-30 20:32:02 +0000,http://finance.yahoo.com/news/dbv-technologies-bionet-asia-geneva-203202751.html?.tsrc=rss,"   DBV Technologies, BioNet-Asia and Geneva University Hospitals Announce Phase I Trial Results of Viaskin rPT in Pertussis Booster Vaccination PARIS, BANGKOK and GENEVA March 30, 2017 - DBV Technologies ..."
DBVT,DBVT:UW,BBG0076D3TP5,"DBV Technologies, BioNet-Asia and Geneva University Hospitals Announce Phase I Trial Results of Viaskin rPT in Pertussis Booster Vaccination",2017-03-30 20:32:02 +0000,http://finance.yahoo.com/news/dbv-technologies-bionet-asia-geneva-203202751.html,"[GlobeNewswire] - DBV Technologies, BioNet-Asia and Geneva University Hospitals Announce Phase I Trial Results of Viaskin rPT in Pertussis Booster Vaccination PARIS, BANGKOK and GENEVA March 30, 2017 - DBV Technologies ..."
DBVT,DBVT:UW,BBG0076D3TP5,DBV TECHNOLOGIES S.A. Financials,2017-03-28 17:04:06 +0000,http://finance.yahoo.com/q/is?s=dbvt&annual,DBV TECHNOLOGIES S.A. Financials
DBVT,DBVT:UW,BBG0076D3TP5,"DBV Technologies : Announces Filing of its 2016 ""Document de Référence"" and Annual Report on Form 20-F",2017-03-22 21:32:02 +0000,http://finance.yahoo.com/news/dbv-technologies-announces-filing-2016-213202748.html,"[GlobeNewswire] - Press Release Montrouge, France, March 22, 2017 DBV Technologies Announces Filing of its 2016 ""Document de Référence"" and Annual Report on Form 20-F ..."
DBVT,DBVT:UW,BBG0076D3TP5,"DBV Technologies : Announces Filing of its 2016 ""Document de Référence"" and Annual Report on Form 20-F",2017-03-22 21:32:02 +0000,http://finance.yahoo.com/news/dbv-technologies-announces-filing-2016-213202748.html?.tsrc=rss,"Press Release Montrouge, France, March 22, 2017 DBV Technologies Announces Filing of its 2016 ""Document de Référence"" and Annual Report on Form 20-F                                                                                                                                                                        ..."
DBVT,DBVT:UW,BBG0076D3TP5,European ADRs Fractionally Higher as Health Care Stocks See Mixed Fortunes,2017-03-20 15:06:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rk_Ax4qp1LU/european-adrs-fractionally-higher-as-health-care-stocks-see-mixed-fortunes-cm762874,American depository receipts of European stocks were 0 1 higher at 127 36 on the Bank of New York Mellon Europe ADR Index on Monday morning American depository receipts of European stocks were 0 1 higher at 127 36 on the Bank of New York Mellon Europe ADR Index on Monday morning Gainers
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies upgraded by Societe Generale,2017-03-16 12:56:54 +0000,http://finance.yahoo.com/q/ud?s=DBVT,DBV Technologies upgraded by Societe Generale
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies Reports Full Year 2016 Financial Results,2017-03-15 06:31:01 +0000,http://finance.yahoo.com/news/dbv-technologies-reports-full-2016-063101767.html,"[GlobeNewswire] - Press Release Montrouge, France, March 15, 2017 DBV Technologies Reports Full Year 2016 Financial Results DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today announced ..."
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies Reports Full Year 2016 Financial Results,2017-03-15 06:31:01 +0000,http://finance.yahoo.com/news/dbv-technologies-reports-full-2016-063101767.html?.tsrc=rss,"Press Release Montrouge, France, March 15, 2017 DBV Technologies Reports Full Year 2016 Financial Results DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today announced ..."
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies Announces Completion of Enrollment of the REALISE Study in Peanut Allergic Children,2017-03-10 06:32:02 +0000,http://finance.yahoo.com/news/dbv-technologies-announces-completion-enrollment-063202004.html,"[GlobeNewswire] - Press Release Montrouge, France, March 10, 2017 DBV Technologies Announces Completion of Enrollment of the REALISE Study in Peanut Allergic Children Higher-than-expected patient demand leads to increased ..."
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies Announces Completion of Enrollment of the REALISE Study in Peanut Allergic Children,2017-03-10 06:32:02 +0000,http://finance.yahoo.com/news/dbv-technologies-announces-completion-enrollment-063202004.html?.tsrc=rss,"Press Release Montrouge, France, March 10, 2017 DBV Technologies Announces Completion of Enrollment of the REALISE Study in Peanut Allergic Children Higher-than-expected patient demand leads to increased ..."
DBVT,DBVT:UW,BBG0076D3TP5,7 Stocks Trending Up With Monster Volume,2017-03-09 12:00:00 +0000,http://finance.yahoo.com/r/55e3b2dd-5901-3a52-a522-f72a0e36d9f3/7-stocks-trending-up-with-monster-volume.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Here's a technical look at how to play a number of stocks trending higher with strong volume.
DBVT,DBVT:UW,BBG0076D3TP5,7 Stocks Trending Up With Monster Volume,2017-03-09 12:00:00 +0000,https://www.thestreet.com/story/14034020/1/7-stocks-trending-up-with-monster-volume.html?puc=yahoo&cm_ven=YAHOO,7 Stocks Trending Up With Monster Volume
DBVT,DBVT:UW,BBG0076D3TP5,European ADRs Edge Lower as Pharma Stocks See Mixed Fortunes,2017-03-07 16:32:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mPvIBt5Vwc0/european-adrs-edge-lower-as-pharma-stocks-see-mixed-fortunes-cm757285,American depository receipts of European stocks were 0 68 lower at 123 61 on the Bank of New York Mellon Europe ADR Index on Tuesday morning American depository receipts of European stocks were 0 68 lower at 123 61 on the Bank of New York Mellon Europe ADR Index on Tuesday morning Decliners
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies : Monthly information regarding the total number of voting rights and total number of shares of the Company,2017-03-07 14:01:01 +0000,http://finance.yahoo.com/news/dbv-technologies-monthly-information-regarding-140101737.html,[GlobeNewswire] - Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE ...
DBVT,DBVT:UW,BBG0076D3TP5,"DBV Technologies :Data at AAAAI 2017 Show Lasting Response and Favorable Safety Profile of Investigational Agent, Viaskin Peanut, Throughout Three Years of Treatment of Peanut Allergic Children",2017-03-05 20:47:01 +0000,http://finance.yahoo.com/news/dbv-technologies-data-aaaai-2017-204701165.html,"[GlobeNewswire] - Press Release Montrouge, France, March 5, 2017 Data at AAAAI 2017 Show Lasting Response and Favorable Safety Profile of Investigational Agent, Viaskin Peanut, Throughout Three Years of Treatment of Peanut ..."
DBVT,DBVT:UW,BBG0076D3TP5,"DBV Technologies :Data at AAAAI 2017 Show Lasting Response and Favorable Safety Profile of Investigational Agent, Viaskin Peanut, Throughout Three Years of Treatment of Peanut Allergic Children",2017-03-05 20:47:01 +0000,http://finance.yahoo.com/news/dbv-technologies-data-aaaai-2017-204701165.html?.tsrc=rss,"Press Release Montrouge, France, March 5, 2017 Data at AAAAI 2017 Show Lasting Response and Favorable Safety Profile of Investigational Agent, Viaskin Peanut, Throughout Three Years of Treatment of Peanut ..."
DBVT,DBVT:UW,BBG0076D3TP5,A patch could fix your peanut-allergy problem,2017-03-05 19:15:00 +0000,http://finance.yahoo.com/news/theres-patch-could-fix-peanut-191500423.html,A patch could fix your peanut-allergy problem
DBVT,DBVT:UW,BBG0076D3TP5,A patch could fix your peanut-allergy problem,2017-03-05 19:15:00 +0000,http://finance.yahoo.com/news/theres-patch-could-fix-peanut-191500423.html?.tsrc=rss,A treatment for one of the most common food allergies out there just got even more data that it's...
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies to Attend Upcoming Investor Conferences,2017-03-01 06:32:02 +0000,http://finance.yahoo.com/news/dbv-technologies-attend-upcoming-investor-063202304.html,"[GlobeNewswire] - Press Release Montrouge, France, March 1, 2017 DBV Technologies to Attend Upcoming Investor Conferences DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today announced ..."
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies to Attend Upcoming Investor Conferences,2017-03-01 06:32:02 +0000,http://finance.yahoo.com/news/dbv-technologies-attend-upcoming-investor-063202304.html?.tsrc=rss,"Press Release Montrouge, France, March 1, 2017 DBV Technologies to Attend Upcoming Investor Conferences DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today announced ..."
DBVT,DBVT:UW,BBG0076D3TP5,"DBV Technologies Reports December 31, 2016 Cash Position",2017-02-20 06:31:01 +0000,http://finance.yahoo.com/news/dbv-technologies-reports-december-31-063101938.html?.tsrc=rss,"Press Release Montrouge, France, February 20, 2017 DBV Technologies Reports December 31, 2016 Cash Position DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), today announced ..."
DBVT,DBVT:UW,BBG0076D3TP5,"DBV Technologies Reports December 31, 2016 Cash Position",2017-02-20 06:31:01 +0000,http://finance.yahoo.com/news/dbv-technologies-reports-december-31-063101938.html,"[GlobeNewswire] - Press Release Montrouge, France, February 20, 2017 DBV Technologies Reports December 31, 2016 Cash Position DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), today announced ..."
DBVT,DBVT:UW,BBG0076D3TP5,European ADRs Edge Lower as Miners Head South,2017-02-14 15:58:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dfJodKci0V4/european-adrs-edge-lower-as-miners-head-south-cm747667,American depository receipts of European stocks were 0 2 lower at 123 83 on the Bank of New York Mellon Europe ADR Index on Tuesday morning American depository receipts of European stocks were 0 2 lower at 123 83 on the Bank of New York Mellon Europe ADR Index on Tuesday morning Decliners
DBVT,DBVT:UW,BBG0076D3TP5,DBV to Present Data at the 2017 AAAAI Meeting Highlighting the Therapeutic Potential of EPIT®,2017-02-10 21:31:01 +0000,http://finance.yahoo.com/news/dbv-present-data-2017-aaaai-213101116.html,"[GlobeNewswire] - Press Release Montrouge, France, February 10, 2017 DBV to Present Data at the 2017 AAAAI Meeting Highlighting the Therapeutic Potential of EPIT ® Eight abstracts, including detailed two-year follow-up ..."
DBVT,DBVT:UW,BBG0076D3TP5,DBV to Present Data at the 2017 AAAAI Meeting Highlighting the Therapeutic Potential of EPIT®,2017-02-10 21:31:01 +0000,http://finance.yahoo.com/news/dbv-present-data-2017-aaaai-213101116.html?.tsrc=rss,"Press Release Montrouge, France, February 10, 2017 DBV to Present Data at the 2017 AAAAI Meeting Highlighting the Therapeutic Potential of EPIT ® Eight abstracts, including detailed two-year follow-up ..."
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies :Monthly information regarding the total number of voting rights and total number of shares of the Company,2017-02-09 10:35:03 +0000,http://finance.yahoo.com/news/dbv-technologies-monthly-information-regarding-103503761.html,[GlobeNewswire] - Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations of the Autorité ...
DBVT,DBVT:UW,BBG0076D3TP5,"ESPR, MDCO Riding High, New Uses For MRK's Old Drug, DBVT In Full Smile(e)",2017-02-06 00:43:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EOS3Jpb0UZU/espr-mdco-riding-high-new-uses-for-mrks-old-drug-dbvt-in-full-smilee-20170206-00016,"ESPR, MDCO Riding High, New Uses For MRK's Old Drug, DBVT In Full Smile(e)"
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies Announces Completion of Enrollment of Phase IIA Study of Viaskin Milk for the Treatment of Pediatric Eosinophilic Esophagitis,2017-02-03 06:32:02 +0000,http://finance.yahoo.com/news/dbv-technologies-announces-completion-enrollment-063202442.html,"[GlobeNewswire] - Press Release Montrouge, France, February 3, 2017 DBV Technologies Announces Completion of Enrollment of Phase IIA Study of Viaskin Milk for the Treatment of Pediatric Eosinophilic Esophagitis SMILEE will ..."
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies Announces Completion of Enrollment of Phase IIA Study of Viaskin Milk for the Treatment of Pediatric Eosinophilic Esophagitis,2017-02-03 06:32:02 +0000,http://finance.yahoo.com/news/dbv-technologies-announces-completion-enrollment-063202442.html?.tsrc=rss,"Press Release Montrouge, France, February 3, 2017 DBV Technologies Announces Completion of Enrollment of Phase IIA Study of Viaskin Milk for the Treatment of Pediatric Eosinophilic Esophagitis SMILEE will ..."
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies to Present at the LEERINK Partners 6th Annual Global Healthcare Conference,2017-01-26 06:33:01 +0000,http://finance.yahoo.com/news/dbv-technologies-present-leerink-partners-063301699.html,"[GlobeNewswire] - Press Release Montrouge, France, January 26, 2017 DBV Technologies to Present at the LEERINK Partners 6th Annual Global Healthcare Conference DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq ..."
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies to Present at the LEERINK Partners 6th Annual Global Healthcare Conference,2017-01-26 06:33:01 +0000,http://finance.yahoo.com/news/dbv-technologies-present-leerink-partners-063301699.html?.tsrc=rss,"Press Release Montrouge, France, January 26, 2017 DBV Technologies to Present at the LEERINK Partners 6th Annual Global Healthcare Conference DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq ..."
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies Announces Financial Calendar 2017,2017-01-09 06:31:01 +0000,http://finance.yahoo.com/news/dbv-technologies-announces-financial-calendar-063101138.html,"[GlobeNewswire] - Press Release Montrouge, France, January 9, 2017 DBV Technologies Announces Financial Calendar 2017 DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), today announced its ..."
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies Announces Financial Calendar 2017,2017-01-09 06:31:01 +0000,http://finance.yahoo.com/news/dbv-technologies-announces-financial-calendar-063101138.html?.tsrc=rss,"Press Release Montrouge, France, January 9, 2017 DBV Technologies Announces Financial Calendar 2017 DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), today announced its ..."
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies presents its Half-year Statement of the Liquidity Contract,2017-01-04 16:58:02 +0000,http://finance.yahoo.com/news/dbv-technologies-presents-half-statement-165802660.html,"[GlobeNewswire] - Regulatory Press Release Montrouge, France, January 4, 2017 DBV Technologies Presents its Half-year Statement of the Liquidity Contract As per the liquidity contract granted by DBV Technologies to NATIXIS, ..."
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies presents its Half-year Statement of the Liquidity Contract,2017-01-04 16:58:02 +0000,http://finance.yahoo.com/news/dbv-technologies-presents-half-statement-165802660.html?.tsrc=rss,"Regulatory Press Release Montrouge, France, January 4, 2017 DBV Technologies Presents its Half-year Statement of the Liquidity Contract As per the liquidity contract granted by DBV Technologies to NATIXIS, ..."
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies : Monthly information regarding the total number of voting rights and total number of shares of the Company,2017-01-04 16:28:01 +0000,http://finance.yahoo.com/news/dbv-technologies-monthly-information-regarding-162801274.html,[GlobeNewswire] - Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations ...
DBVT,DBVT:UW,BBG0076D3TP5,Is DBV Technologies (DBVT) Stock a Solid Choice Right Now?,2017-01-04 15:42:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R_PQ1EMgK7E/is-dbv-technologies-dbvt-stock-a-solid-choice-right-now-cm729211,One stock that might be an intriguing choice for investors right now is DBV Technologies S A DBVT This is because this security in the Medical Biomedical Genetics space is seeing solid earnings estimate revision activity and is in great company from a Zacks Industry Rank perspective
DBVT,DBVT:UW,BBG0076D3TP5,Is DBV Technologies (DBVT) Stock a Solid Choice Right Now?,2017-01-04 13:36:01 +0000,http://finance.yahoo.com/news/dbv-technologies-dbvt-stock-solid-133601246.html?.tsrc=rss,"DBV Technologies (DBVT) in the Medical-Biomedical/Genetics space is seeing solid earnings estimate revision activity, and is a great company from a Zacks Industry Rank perspective."
DBVT,DBVT:UW,BBG0076D3TP5,Is DBV Technologies (DBVT) Stock a Solid Choice Right Now?,2017-01-04 13:36:01 +0000,http://finance.yahoo.com/news/dbv-technologies-dbvt-stock-solid-133601246.html,Is DBV Technologies (DBVT) Stock a Solid Choice Right Now?
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies :Monthly information regarding the total number of voting rights and total number of shares of the Company,2016-12-07 15:01:01 +0000,http://finance.yahoo.com/news/dbv-technologies-monthly-information-regarding-150101331.html,[GlobeNewswire] - Monthly information regarding the total number of voting rights and total number of shares of the Company (Article 223-16 of the General Regulations ...
DBVT,DBVT:UW,BBG0076D3TP5,Lysogene Appoints David Schilansky to Board of Directors,2016-12-07 12:00:00 +0000,http://finance.yahoo.com/news/lysogene-appoints-david-schilansky-board-120000571.html,"[GlobeNewswire] - PARIS, Dec. 07, 2016-- Lysogene, a biopharmaceutical company specializing in gene therapy for rare central nervous system diseases, appointed David Schilansky to the board of directors, as a non-executive, ..."
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies SA – ADR (DBVT): Smart Money Is Slowly Coming Back,2016-12-05 03:20:20 +0000,http://www.insidermonkey.com/blog/dbv-technologies-sa-adr-dbvt-smart-money-is-slowly-coming-back-498433/,DBV Technologies SA – ADR (DBVT): Smart Money Is Slowly Coming Back
DBVT,DBVT:UW,BBG0076D3TP5,Is DBV Technologies (DBVT) Stock a Solid Choice Right Now?,2016-12-01 18:19:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oHqv-bE3nYU/is-dbv-technologies-dbvt-stock-a-solid-choice-right-now-cm716479,One stock that might be an intriguing choice for investors right now is DBV Technologies S A DBVT This is because this security in the Medical Biomedical and Genetics space is seeing solid earnings estimate revision activity and is in great company from a Zacks Industry Rank
DBVT,DBVT:UW,BBG0076D3TP5,Is DBV Technologies (DBVT) Stock a Solid Choice Right Now?,2016-12-01 16:10:04 +0000,http://finance.yahoo.com/news/dbv-technologies-dbvt-stock-solid-161004989.html,Is DBV Technologies (DBVT) Stock a Solid Choice Right Now?
DBVT,DBVT:UW,BBG0076D3TP5,"European ADRs Edge Lower as Manufacturers, Pharma Stocks See Mixed Fortunes",2016-11-23 16:24:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dNqxWhufE08/european-adrs-edge-lower-as-manufacturers-pharma-stocks-see-mixed-fortunes-cm713313,American depository receipts of European stocks were 0 8 lower at 114 08 on the Bank of New York Mellon Europe ADR Index on Wednesday morning American depository receipts of European stocks were 0 8 lower at 114 08 on the Bank of New York Mellon Europe ADR Index on Wednesday morning Decliners
DBVT,DBVT:UW,BBG0076D3TP5,"DBV Technologies, BioNet-Asia and Geneva University Hospitals Complete Dosing in First Cohort of Phase I Study of Viaskin rPT for Booster Vaccination Against Pertussis",2016-11-17 06:32:01 +0000,http://finance.yahoo.com/news/dbv-technologies-bionet-asia-geneva-063201911.html,"[GlobeNewswire] - DBV Technologies, BioNet-Asia and Geneva University Hospitals Complete Dosing in First Cohort of Phase I Study of Viaskin rPT for Booster Vaccination Against Pertussis DSMB expressed no safety concerns ..."
DBVT,DBVT:UW,BBG0076D3TP5,"DBV Technologies, BioNet-Asia and Geneva University Hospitals Complete Dosing in First Cohort of Phase I Study of Viaskin rPT for Booster Vaccination Against Pertussis",2016-11-17 06:30:00 +0000,http://au.finance.yahoo.com/news/dbv-technologies-bionet-asia-geneva-063000312.html,"[Business Wire] - PARIS, BANGKOK & GENEVA--(BUSINESSWIRE)-- DBV Technologies (Euronext: DBV – ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), the Geneva University Hospitals (HUG) and BioNet-Asia Co. Ltd today announced that in a planned interim assessment of the Phase I trial of Viaskin rPT for booster immunization against Bordetella pertussis, the independent Data and Safety Monitoring Board (DSMB) concluded that there were no safety concerns with the administration of Viaskin rPT 25 ųg in the first subject cohort. Based on this review, enrollment in the trial has continued as planned, with dosing of Viaskin rPT 50 ųg commencing in the second subject cohort. The Viaskin rPT pertussis booster vaccination program intends to test the ability of DBV’s needleless and adjuvant-free patch technology, Viaskin, to epicutaneously deliver two different doses of BioNet’s genetically detoxified, recombinant pertussis toxin for boosting immunity against whooping cough."
DBVT,DBVT:UW,BBG0076D3TP5,Monthly information regarding the total number of voting rights and total number of shares of the Company,2016-11-16 10:18:15 +0000,http://www.publicnow.com/view/84EB941447DE9B54E60715CFB4F5569768100944,[at noodls] - (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers) Market : NYSE Euronext Paris ISIN Code: FR 0010417345 Date Total number of shares Total number of voting rights 16/11/2016 ...
DBVT,DBVT:UW,BBG0076D3TP5,"DBV Technologies Announces Poster Presentations at the 2016 American College of Allergy, Asthma, and Immunology Meeting",2016-11-12 00:32:02 +0000,http://finance.yahoo.com/news/dbv-technologies-announces-poster-presentations-003202505.html,"[GlobeNewswire] - Press Release Montrouge, France, November 11, 2016 DBV Technologies Announces Poster Presentations at the 2016 American College of Allergy, Asthma, and Immunology Meeting DBV Technologies (Euronext: DBV ..."
DBVT,DBVT:UW,BBG0076D3TP5,"DBV Technologies Announces Poster Presentations at the 2016 American College of Allergy, Asthma, and Immunology Meeting",2016-11-12 00:30:00 +0000,http://uk.finance.yahoo.com/news/dbv-technologies-announces-poster-presentations-003000546.html,"DBV Technologies Announces Poster Presentations at the 2016 American College of Allergy, Asthma, and Immunology Meeting"
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies to Attend Upcoming Investor Conferences,2016-11-10 08:51:09 +0000,http://www.publicnow.com/view/97FE3866B468F971D310F9FB56AF9F63E21CFCEA,"[at noodls] - Press Release Montrouge, France, November 10, 2016 DBV Technologies to Attend Upcoming Investor Conferences DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), today announced ..."
DBVT,DBVT:UW,BBG0076D3TP5,Blog Coverage DBV Technologies Executes Phase II Study of VIASKIN Milk for Treatment of Milk Allergic Patients,2016-11-09 13:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-dbv-technologies-executes-131500548.html,"[Accesswire] - Upcoming AWS Coverage on IDEXX Laboratories Post-Earnings Results LONDON, UK / ACCESSWIRE / November 9, 2016 / Active Wall St. blog coverage looks at the headline from the French biopharmaceutical firm ..."
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies Completes Enrollment of Phase II Study of Viaskin Milk for the Treatment of Milk Allergic Patients,2016-11-08 09:05:11 +0000,http://www.publicnow.com/view/6B31EB2D26C583EEFBD8213FDE5857DB9F5AB420,"[at noodls] - Press Release Montrouge, France, November 8, 2016 DBV Technologies Completes Enrollment of Phase II Study of Viaskin Milk for the Treatment of Milk Allergic Patients Most advanced product candidate for ..."
DBVT,DBVT:UW,BBG0076D3TP5,"MDCO Tastes Bitter, PRTO Awaits Phase 3 Data In Dec., It''s Time To Cherish IONS",2016-11-08 05:07:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/M0DGzlGr9Js/mdco-tastes-bitter-prto-awaits-phase-3-data-in-dec-its-time-to-cherish-ions-20161108-00167,"MDCO Tastes Bitter, PRTO Awaits Phase 3 Data In Dec., It''s Time To Cherish IONS"
DBVT,DBVT:UW,BBG0076D3TP5,"DBV Technologies Reports September 30, 2016 Cash Position",2016-11-03 09:37:10 +0000,http://www.publicnow.com/view/9BB5C2929F8EB500607B714736133CDAA8D9EB60,"[at noodls] - Press Release Montrouge, France, November 3, 2016 DBV Technologies Reports September 30, 2016 Cash Position DBV Technologies, (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), today announced ..."
DBVT,DBVT:UW,BBG0076D3TP5,There's a patch that could fix your peanut allergy problem,2016-11-01 14:55:00 +0000,http://finance.yahoo.com/news/theres-patch-could-fix-peanut-145500230.html,There's a patch that could fix your peanut allergy problem
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies Announces Publication of Positive Viaskin Peanut Data From NIAID-Sponsored Phase II Academic Study in the Journal of Allergy and Clinical Immunology,2016-10-26 20:31:01 +0000,http://finance.yahoo.com/news/dbv-technologies-announces-publication-positive-203101108.html,"[GlobeNewswire] - Press Release Montrouge, France, October 26, 2016 DBV Technologies Announces Publication of Positive Viaskin Peanut Data From NIAID-Sponsored Phase II Academic Study in the Journal of Allergy and Clinical ..."
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies Announces Publication of Positive Viaskin Peanut Data From NIAID-Sponsored Phase II Academic Study in the Journal of Allergy and Clinical Immunology,2016-10-26 20:30:00 +0000,http://uk.finance.yahoo.com/news/dbv-technologies-announces-publication-positive-203000620.html,DBV Technologies Announces Publication of Positive Viaskin Peanut Data From NIAID-Sponsored Phase II Academic Study in the Journal of Allergy and Clinical Immunology
DBVT,DBVT:UW,BBG0076D3TP5,Topline Results from Two-Year Follow-Up Study of Viaskin Peanut Show Long-Lasting and High Levels of Desensitization to Peanut,2016-10-25 10:51:03 +0000,http://www.publicnow.com/view/9A2C2E19D4BDA4A60CD240942E435D022B4916EA,"[at noodls] - Press Release Montrouge, France, October 24, 2016 Topline Results from Two-Year Follow-Up Study of Viaskin Peanut Show Long-Lasting and High Levels of Desensitization to Peanut Favorable safety and high ..."
DBVT,DBVT:UW,BBG0076D3TP5,"INO Slips On Clinical Hold, MRK Gets FDA Nod, Be All Ears For AKAO",2016-10-25 03:29:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-zhnSBzNTVg/ino-slips-on-clinical-hold-mrk-gets-fda-nod-be-all-ears-for-akao-20161025-00106,"INO Slips On Clinical Hold, MRK Gets FDA Nod, Be All Ears For AKAO"
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies: Topline Results from Two-Year Follow-Up Study of Viaskin Peanut Show Long-Lasting and High Levels of Desensitization to Peanut,2016-10-24 20:31:01 +0000,http://finance.yahoo.com/news/dbv-technologies-topline-results-two-203101085.html,DBV Technologies: Topline Results from Two-Year Follow-Up Study of Viaskin Peanut Show Long-Lasting and High Levels of Desensitization to Peanut
DBVT,DBVT:UW,BBG0076D3TP5,Topline Results from Two-Year Follow-Up Study of Viaskin Peanut Show Long-Lasting and High Levels of Desensitization to Peanut,2016-10-24 20:30:00 +0000,http://uk.finance.yahoo.com/news/topline-results-two-study-viaskin-203000277.html,Topline Results from Two-Year Follow-Up Study of Viaskin Peanut Show Long-Lasting and High Levels of Desensitization to Peanut
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies Receives FDA Fast Track Designation for Viaskin Milk for the Treatment of Cow’s Milk Protein Allergy,2016-09-21 07:41:08 +0000,http://www.publicnow.com/view/16D7FE1B1DEBAD0D30057AADE5C572CA8C6DA42B,"[at noodls] - Press Release Montrouge, France, September 21, 2016 DBV Technologies Receives FDA Fast Track Designation for Viaskin Milk for the Treatment of Cow's Milk Protein Allergy DBV first to announce Fast Track ..."
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies Receives FDA Fast Track Designation for Viaskin Milk for the Treatment of Cow's Milk Protein Allergy,2016-09-21 05:31:02 +0000,http://finance.yahoo.com/news/dbv-technologies-receives-fda-fast-053102693.html,DBV Technologies Receives FDA Fast Track Designation for Viaskin Milk for the Treatment of Cow's Milk Protein Allergy
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies Gets FDA Fast Track Designation For Viaskin Milk,2016-09-21 01:42:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pDZmy-hAFiM/dbv-technologies-gets-fda-fast-track-designation-for-viaskin-milk-20160921-00018,DBV Technologies Gets FDA Fast Track Designation For Viaskin Milk
DBVT,DBVT:UW,BBG0076D3TP5,5 Stocks That Healthcare Fund Deerfield Management Was Buying in Q2,2016-09-16 17:41:27 +0000,http://www.insidermonkey.com/blog/5-stocks-that-healthcare-fund-deerfield-management-was-buying-in-q2-474819/,5 Stocks That Healthcare Fund Deerfield Management Was Buying in Q2
DBVT,DBVT:UW,BBG0076D3TP5,Monthly information regarding the total number of voting rights and total number of shares of the Company,2016-09-12 12:48:04 +0000,http://www.publicnow.com/view/C79298F8CE6E120428AE8A8F0C66E916EB598F6D,"[at noodls] - DBV Technologies, BioNet-Asia and the Geneva University Hospitals Initiate Phase I Study of Viaskin rPT for Pertussis Booster Vaccination Proof of concept trial will evaluate the safety and immunogenicity ..."
DBVT,DBVT:UW,BBG0076D3TP5,"DBV Technologies, BioNet-Asia and the Geneva University Hospitals Initiate Phase I Study of Viaskin rPT for Pertussis Booster Vaccination",2016-09-06 05:38:04 +0000,http://www.publicnow.com/view/A3219774408135095EE666F1CE35477580CDE291,"[at noodls] - DBV Technologies, BioNet-Asia and the Geneva University Hospitals Initiate Phase I Study of Viaskin rPT for Pertussis Booster Vaccination Proof of concept trial will evaluate the safety and immunogenicity ..."
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies to Attend Upcoming Investor Conferences,2016-09-01 05:36:07 +0000,http://finance.yahoo.com/news/dbv-technologies-attend-upcoming-investor-053607130.html,"[GlobeNewswire] - MONTROUGE, France -- DBV Technologies, (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage specialty biopharmaceutical company, today announced that members of its management ..."
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies Announces Expansion of Clinical Program of Viaskin Peanut for the Treatment of Peanut Allergy,2016-08-02 07:21:06 +0000,http://www.publicnow.com/view/CB718C79B8A0706A5605BDCE80FAE32B44CB0190,"[at noodls] - Press Release Montrouge, France, August 1, 2016 DBV Technologies Announces Expansion of Clinical Program of Viaskin Peanut for the Treatment of Peanut Allergy St rategic Investment Enhances Largest Global ..."
DBVT,DBVT:UW,BBG0076D3TP5,"SMA Data Endears IONS To Investors, PFE Opens Wallet, Busy Months Ahead For DRRX",2016-08-02 02:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lxLxQU9aNRk/sma-data-endears-ions-to-investors-pfe-opens-wallet-busy-months-ahead-for-drrx-20160802-00037,"SMA Data Endears IONS To Investors, PFE Opens Wallet, Busy Months Ahead For DRRX"
DBVT,DBVT:UW,BBG0076D3TP5,First Half of 2016 Condensed Consolidated Financial Statements,2016-07-28 09:08:06 +0000,http://www.publicnow.com/view/A2DD6952E2459098648DFAD2DAA4032FBE03C039,[at noodls] - FIRST HALF OF 2016 CONDENSED CONSOLIDATED FINANCIAL STATEMENTS The epicutaneous immunotherapy company CONTENT I - FIRST HALF 2016 CONDENSED CONSOLIDATED FINANCIAL STATEMENTS II - MANAGEMENT DISCUSSION ...
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies Reports Interim Financial Results for the First Half of 2016,2016-07-28 05:38:05 +0000,http://www.publicnow.com/view/0B1C050158BAAD518C28D0D489FCA993EED6E62D,"[at noodls] - Press Release Montrouge, France, July 28, 2016 DBV Technologies Reports Interim Financial Results for the First Half of 2016 DBV Technologies, (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: ..."
DBVT,DBVT:UW,BBG0076D3TP5,"DBV Technologies SA :DBVT-US: Earnings Analysis: For the six months ended December 31, 2015 : July 26, 2016",2016-07-26 14:43:44 +0000,http://www.capitalcube.com/blog/index.php/dbv-technologies-sa-dbvt-us-earnings-analysis-for-the-six-months-ended-december-31-2015-july-26-2016/,"DBV Technologies SA :DBVT-US: Earnings Analysis: For the six months ended December 31, 2015 : July 26, 2016"
DBVT,DBVT:UW,BBG0076D3TP5,The Most Popular French Stocks Among Hedge Funds,2016-07-15 13:36:56 +0000,http://www.insidermonkey.com/blog/the-most-popular-french-stocks-among-hedge-funds-464471/,The Most Popular French Stocks Among Hedge Funds
DBVT,DBVT:UW,BBG0076D3TP5,Half year update on the DBV Technologies liquidity agreement,2016-07-12 08:53:08 +0000,http://www.publicnow.com/view/1956EAD10B99A02722899080DE43715267AFE03A,"[at noodls] - 4b85791b-d450-4900-8299-2e9b48c7af90.pdf Press Release Montrouge, France, July 11th, 2016 Half year update on the DBV Technologies liquidity agreement Montrouge, France, July 11th - As per the liquidity ..."
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies Proudly Welcomes Dr. Lucia Septien as Chief Medical Officer,2016-07-05 05:34:04 +0000,http://finance.yahoo.com/news/dbv-technologies-proudly-welcomes-dr-053404254.html,"[GlobeNewswire] - MONTROUGE, France -- DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage specialty biopharmaceutical company, today announced the appointment of Lucia Septien, ..."
DBVT,DBVT:UW,BBG0076D3TP5,European ADRs Extend Gains as Pharma Stocks Surge,2016-06-28 16:02:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/edB5Iq060GE/european-adrs-extend-gains-as-pharma-stocks-surge-cm642104,"American depository receipts of European stocks were trading 2.3% higher at 114.35 on the Bank of New York Mellon Europe ADR Index on Tuesday morning. Gainers in Continental Europe were led by Flamel Technologies ( FLML ), a French"
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies Announces Completion of Recruitment in Global Phase III Study of Viaskin Peanut for the Treatment of Peanut Allergic Children,2016-06-27 20:41:01 +0000,http://www.publicnow.com/view/A2F65A7995B6FD0E154787F30C3032F83754F323,"[at noodls] - 33131379-e6fe-42e2-9f48-845ca6ea17ef.pdf Press Release Montrouge, France, June 27, 2016 DBV Technologies Announces Completion of Recruitment in Global Phase III Study of Viaskin Peanut for the Treatment ..."
DBVT,DBVT:UW,BBG0076D3TP5,DBV Announced Results of its 2016 Annual Meeting of Shareholders,2016-06-21 20:39:08 +0000,http://www.publicnow.com/view/C64C4622597EAEB92F1A7E9C2871409E82831EF2,"[at noodls] - 7c68e2bb-6bc1-4354-adce-6bc5c46dbb0e.pdf Regulated Information Montrouge, France, June 21, 2016 DBV Announced Results of its 2016 Annual Meeting of Shareholders Adoption of all resolutions submitted to ..."
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies Expands its Board of Directors with the Appointments of Claire Giraut and Maïlys Ferrere,2016-06-21 20:39:08 +0000,http://www.publicnow.com/view/DC8A3013FEAF2E35CF4DF5E936884FAC24C2C3EF,"[at noodls] - 1003aa0c-cf5a-462d-b1eb-434a5826f82b.pdf Press Release Montrouge, France, June 21, 2016 DBV Technologies Expands its Board of Directors with the Appointments of Claire Giraut and Maïlys Ferrere DBV Technologies ..."
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies Announced Results of its 2016 Annual Meeting of Shareholders,2016-06-21 20:36:44 +0000,http://finance.yahoo.com/news/dbv-technologies-announced-results-2016-203644027.html,"[GlobeNewswire] - Montrouge, France -- DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage specialty biopharmaceutical company, held today its Combined Shareholders' Meeting, ..."
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies Expands its Board of Directors with the Appointments of Claire Giraut and Mailys Ferrere,2016-06-21 20:32:50 +0000,http://finance.yahoo.com/news/dbv-technologies-expands-board-directors-203250915.html,"[GlobeNewswire] - Montrouge, France -- DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage specialty biopharmaceutical company, today announced the appointment of Claire Giraut ..."
DBVT,DBVT:UW,BBG0076D3TP5,Will Accenture's (ACN) Q3 Earnings Beat Expectations?,2016-06-20 14:10:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Z9Qw2FGCYmQ/will-accentures-acn-q3-earnings-beat-expectations-cm637565,We expect Accenture plcACN to beat expectations when it reports third quarter fiscal 2016 results on Jun 23. Why a Likely Positive Surprise? Our proven model shows that Accenture is likely to beat earnings because it has the right
DBVT,DBVT:UW,BBG0076D3TP5,Adobe Systems (ADBE): A Surprise in Q2 Earnings Release?,2016-06-17 15:11:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rLcu702-Evw/adobe-systems-adbe-a-surprise-in-q2-earnings-release-cm636948,"Adobe Systems IncorporatedADBE is slated to report second quarter fiscal 2016 results on Jun 21. Last quarter, the company recorded a positive earnings surprise of 10.64%. Let's see how things are shaping up for this announcement. Factors to Consider"
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies to Present at the JMP Securities Life Sciences Conference,2016-06-16 20:49:02 +0000,http://www.publicnow.com/view/E9FDF034C2FF52CF0B78393752F9221CCC3045AC,"[at noodls] - e12292e5-73d9-4d07-b8a9-a8d387c5395c.pdf Press Release Montrouge, France, June 16, 2016 DBV Technologies to Present at the JMP Securities Life Sciences Conference DBV Technologies, (Euronext: DBV - ISIN: ..."
DBVT,DBVT:UW,BBG0076D3TP5,Late-Breaking Presentation at EAACI Highlights Viaskin® Peanut Data Providing Biomarker Insights for Monitoring Treatment Progression,2016-06-15 20:39:04 +0000,http://www.publicnow.com/view/71D8860CAEF3260324250A5B028AD10E75CAB870,"[at noodls] - 1de329d1-d483-4fe0-b493-29c5bb5a77c7.pdf Press Release Vienna, Austria, June 15, 2016 Late-Breaking Presentation at EAACI Highlights Viaskin® Peanut Data Providing Biomarker Insights for Monitoring Treatment ..."
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies: Late-Breaking Presentation at EAACI Highlights Viaskin(r) Peanut Data Providing Biomarker Insights for Monitoring Treatment Progression,2016-06-15 20:34:04 +0000,http://finance.yahoo.com/news/dbv-technologies-breaking-presentation-eaaci-203404772.html,[GlobeNewswire] - Early-Stage Proprietary Model Suggests that Serum Biomarkers may help Monitor Treatment Progression with Viaskin Peanut
DBVT,DBVT:UW,BBG0076D3TP5,European ADRs Head South as Pharma Stocks Contract,2016-06-13 15:38:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/riypWZ44HpE/european-adrs-head-south-as-pharma-stocks-contract-cm634606,"American depository receipts of European stocks were 0.7% lower at 118.60 on the Bank of New York Mellon Europe ADR Index on Monday morning. Decliners in Continental Europe were led by CGG ( CGG ), a manufacturer of geophysical"
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies Announces Publication of Preclinical Data in JACI Suggesting EPIT® Provides Sustained Protection Against Anaphylaxis,2016-06-13 05:39:08 +0000,http://www.publicnow.com/view/991E58D0D93EC3D429383ACD1DDAB2A8CED6B0A7,"[at noodls] - 41ce98a8-755a-422c-b251-7545aa92ab9a.pdf Press Release Montrouge, France, June 13, 2016 DBV Technologies Announces Publication of Preclinical Data in JACI Suggesting EPIT® Provides Sustained Protection ..."
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies Announces Publication of Preclinical Data in JACI Suggesting EPIT(r) Provides Sustained Protection Against Anaphylaxis,2016-06-13 05:36:45 +0000,http://finance.yahoo.com/news/dbv-technologies-announces-publication-preclinical-053645198.html,[GlobeNewswire] - DBV Technologies Announces Publication of Preclinical Data in JACI Suggesting EPIT(R) Provides Sustained Protection Against Anaphylaxis
DBVT,DBVT:UW,BBG0076D3TP5,Science Applications (SAIC) Q1 Earnings: What to Expect?,2016-06-09 17:18:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Acdh5n1vgfs/science-applications-saic-q1-earnings-what-to-expect-cm633051,"Science Applications International Corporation SAIC is set to report first quarter fiscal 2017 results on Jun 13. Last quarter, the company posted a positive earnings surprise of 15.6%. Let us see how things are shaping up for this announcement. Factors"
DBVT,DBVT:UW,BBG0076D3TP5,"DBV Technologies Announces Appointment of Leading Japanese Allergist, Dr. Motohiro Ebisawa, to its Scientific Advisory Board",2016-06-07 20:38:03 +0000,http://www.publicnow.com/view/D5AC64C75A609F3B514DA7948592202C964F9BB6,"[at noodls] - 91a2f551-8c7b-4bf3-af1f-625018261527.pdf Press Release Montrouge, France, June 7, 2016 DBV Technologies Announces Appointment of Leading Japanese Allergist, Dr. Motohiro Ebisawa, to its Scientific Advisory ..."
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies Forms 'Magic' Partnership With Nestle,2016-06-07 20:11:00 +0000,http://www.forbes.com/sites/genemarcial/2016/06/07/dbv-tech-forms-magic-partnership-with-nestle/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,DBV Technologies Forms 'Magic' Partnership With Nestle
DBVT,DBVT:UW,BBG0076D3TP5,"June 21, 2016 General Assembly",2016-06-06 17:08:01 +0000,http://www.publicnow.com/view/E0BA57BE0BBA2309D50273399D122C87A57C9003,"[at noodls] - dcc6eb60-0bde-4176-b182-85053dc94bf5.pdf DBV TECHNOLOGIES Société anonyme (public limited company) with a Board of Directors and social capital of € 2,431,345,30. Registered office: 177-181 avenue Pierre ..."
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies Data at EAACI 2016 Highlight Its Expansive Product Development in Food Allergies,2016-06-01 05:38:01 +0000,http://finance.yahoo.com/news/dbv-technologies-data-eaaci-2016-053801937.html,[GlobeNewswire] - Nine Presentations Continue to Support the Potential Use of the Viaskin(R) Technology in Food Allergies
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies Data at EAACI 2016 Highlight Its Expansive Product Development in Food Allergies,2016-06-01 05:33:02 +0000,http://www.publicnow.com/view/C5BDB9391E516B7FEE63F207AF429E9FF7AC82BE,"[at noodls] - 432489a8-f3c6-41ee-aa5d-2d4b80b59d03.pdf Press Release Montrouge, France, June 1, 2016 DBV Technologies Data at EAACI 2016 Highlight Its Expansive Product Development in Food Allergies Nine Presentations ..."
DBVT,DBVT:UW,BBG0076D3TP5,Nestle SA (ADR) Seeks to Develop a Milk Allergy Test for Infants,2016-06-01 00:05:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XdlvA8xx4e4/nestle-sa-adr-seeks-to-develop-a-milk-allergy-test-for-infants-cm628703,Nestle SA (ADR) ( NSRGY ) is looking to help develop a milk allergy test for infants. Source WikipediaNestle will be working with  DBV Technologies SA ADR ( DBVT )
DBVT,DBVT:UW,BBG0076D3TP5,Nestle Partnership Gives DBV Investors a Treat,2016-05-31 17:51:17 +0000,http://blogs.wsj.com/moneybeat/2016/05/31/nestle-partnership-gives-dbv-investors-a-treat/?mod=yahoo_hs,Nestle Partnership Gives DBV Investors a Treat
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies and Nestlé Health Science Form Collaboration to Develop and Commercialize a Novel Diagnostic Test for Pediatric Milk Allergy,2016-05-31 13:02:06 +0000,http://www.publicnow.com/view/B1A4E775568066E45F889184B2D7E46A2CB01663,"[at noodls] - d95d8d73-2fec-45f9-864b-d781e4f02da8.pdf Press Release Montrouge, France, May 31, 2016 DBV Technologies and Nestlé Health Science Form Collaboration to Develop and Commercialize a Novel Diagnostic Test ..."
DBVT,DBVT:UW,BBG0076D3TP5,European Markets Fell On Disappointing Data,2016-05-31 11:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/T9FhbLd8Phk/european-markets-fell-on-disappointing-data-20160531-00793,European Markets Fell On Disappointing Data
DBVT,DBVT:UW,BBG0076D3TP5,"Nestle, on health kick, moves into milk allergy testing",2016-05-31 10:47:37 +0000,http://uk.finance.yahoo.com/news/nestle-health-kick-moves-milk-080858572.html,"Nestle, on health kick, moves into milk allergy testing"
DBVT,DBVT:UW,BBG0076D3TP5,European Shares Turn Lower After Mixed Data,2016-05-31 07:08:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WgQLmHFE8g0/european-shares-turn-lower-after-mixed-data-20160531-00224,European Shares Turn Lower After Mixed Data
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies and Nestle Health Science Form Collaboration to Develop and Commercialize a Novel Diagnostic Test for Pediatric Milk Allergy,2016-05-31 05:06:09 +0000,http://finance.yahoo.com/news/dbv-technologies-nestle-health-science-050609792.html,"[GlobeNewswire] - BAGNEUX, France --"
DBVT,DBVT:UW,BBG0076D3TP5,"DBV Technologies: Mixed General Assembly of June 21, 2016 Procedures for obtaining preparatory documents for the Assembly",2016-05-30 20:46:33 +0000,http://finance.yahoo.com/news/dbv-technologies-mixed-general-assembly-204633834.html,"[GlobeNewswire] - MONTROUGE, France -- DBV Technologies, (Euronext: DBV - ISIN: FR0010417345 - NASDAQ: DBVT), a clinical-stage specialty biopharmaceutical company, announces that it will hold its Mixed General Assembly ..."
DBVT,DBVT:UW,BBG0076D3TP5,"Mixed General Assembly of June 21, 2016 Procedures for obtaining preparatory documents for the Assembly",2016-05-30 20:40:08 +0000,http://www.publicnow.com/view/132F9EEF13C0C1ACB5EC3373E208097E3F7E16F8,"[at noodls] - d2180379-c522-4698-a4d3-73ce8382f3ca.pdf Regulated Information Montrouge, France, May 30, 2016 Mixed General Assembly of June 21, 2016 Procedures for obtaining preparatory documents for the Assembly DBV ..."
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies to Attend Upcoming Investor Conferences,2016-05-20 07:33:07 +0000,http://www.publicnow.com/view/94D99730AD087A3C563C97FE6B59B413A72579B7,"[at noodls] - d7e2ea5b-ff70-4fbe-a854-0decd25899be.pdf Press Release Montrouge, France, May 20, 2016 DBV Technologies to Attend Upcoming Investor Conferences DBV Technologies, (Euronext: DBV - ISIN: FR0010417345 - Nasdaq ..."
DBVT,DBVT:UW,BBG0076D3TP5,European ADRs Edge Higher as Banks Advance,2016-05-18 15:13:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_QEEzGoN710/european-adrs-edge-higher-as-banks-advance-cm622783,"American depository receipts of European stocks were 0.3% higher at 120.39 on the Bank of New York Mellon Europe ADR Index on Wednesday morning. Gainers in Continental Europe were led by STMicroelectronics New York Shares ( STM ), an"
DBVT,DBVT:UW,BBG0076D3TP5,Monthly information regarding the total number of voting rights and total number of shares of the Company,2016-05-10 15:58:07 +0000,http://www.publicnow.com/view/AD36669A91EC5748CE478E1BFDC3391ADA1D3787,[at noodls] - Société (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers) Market : NYSE Euronext Paris ISIN Code: FR 0010417345 Date Total number of shares Total number ...
DBVT,DBVT:UW,BBG0076D3TP5,"DBV Technologies Reports March 31, 2016 Cash Position",2016-04-29 05:54:49 +0000,http://www.publicnow.com/view/B07F9234B12610C11A575E00C0E067A205B6E927,"[at noodls] - 71c28dfa-2717-4a77-a8eb-dcccefa1dc24.pdf Press Release Montrouge, France, April 29, 2016 DBV Technologies Reports March 31, 2016 Cash Position DBV Technologies, (Euronext: DBV - ISIN: FR0010417345 - Nasdaq ..."
DBVT,DBVT:UW,BBG0076D3TP5,20-F Form,2016-04-28 21:41:26 +0000,http://www.publicnow.com/view/C6DD483D04EFC0ACE1494C717094C71D6D27FD36,"[at noodls] - printmgr file UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 ..."
DBVT,DBVT:UW,BBG0076D3TP5,European ADRs Edge Higher in Thursday Trading,2016-04-14 17:24:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OBJkBm2wpgM/european-adrs-edge-higher-in-thursday-trading-cm606457,"American depository receipts of European stocks were trading 0.03% higher at 123.19 on the Bank of New York Mellon Europe ADR Index Thursday morning. In continental Europe, the gainers were led Germany based 3D printer manufacturer Voxelkjet AG, which"
DBVT,DBVT:UW,BBG0076D3TP5,"European ADRs Advance as Geophysical Equipment Maker CGG Jumps 6 Per Cent, Financial Services Stocks Lower",2016-04-06 16:16:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x94hjJ4j5pg/european-adrs-advance-as-geophysical-equipment-maker-cgg-jumps-6-per-cent-financial-services-stocks-lower-cm602509,"American depository receipts of European stocks were 0.9% higher at 118.13 on the Bank of New York Mellon Europe ADR Index on Wednesday morning. Gainers in Continental Europe were led by CGG ( CGG ), a manufacturer of geophysical"
DBVT,DBVT:UW,BBG0076D3TP5,There's a patch that could fix your allergy problem,2015-12-07 22:01:00 +0000,http://finance.yahoo.com/news/theres-patch-could-fix-allergy-220100141.html,There's a patch that could fix your allergy problem
DBVT,DBVT:UW,BBG0076D3TP5,Here is What Hedge Funds Think About DBV Technologies SA – ADR (DBVT),2015-11-30 16:17:52 +0000,http://www.insidermonkey.com/blog/here-is-what-hedge-funds-think-about-dbv-technologies-sa-adr-dbvt-394907/,Here is What Hedge Funds Think About DBV Technologies SA – ADR (DBVT)
DBVT,DBVT:UW,BBG0076D3TP5,Here is What Hedge Funds Think About Nordic American Tanker Ltd (NAT),2015-11-29 21:56:55 +0000,http://www.insidermonkey.com/blog/here-is-what-hedge-funds-think-about-nordic-american-tanker-ltd-nat-391565/,Here is What Hedge Funds Think About Nordic American Tanker Ltd (NAT)
DBVT,DBVT:UW,BBG0076D3TP5,Is Smart Money Keen On FCB Financial Holdings Inc (FCB)?,2015-11-24 00:16:50 +0000,http://www.insidermonkey.com/blog/is-smart-money-keen-on-fcb-financial-holdings-inc-fcb-387434/,Is Smart Money Keen On FCB Financial Holdings Inc (FCB)?
DBVT,DBVT:UW,BBG0076D3TP5,Fresh Focus On Relief For Peanut Allergy Sufferers,2015-11-06 15:51:00 +0000,http://www.forbes.com/sites/genemarcial/2015/11/06/fresh-focus-on-relief-for-peanut-allergy-sufferers/?utm_campaign=yahootix&partner=yahootix,Fresh Focus On Relief For Peanut Allergy Sufferers
DBVT,DBVT:UW,BBG0076D3TP5,"Archived Event: DBV Technologies S.A. (DBVT), Interview with Dr. Pierre-Henri Benhamou",2015-10-30 21:13:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/V1Zf4CEhkOA/archived-event-dbv-technologies-sa-dbvt-interview-with-dr-pierre-henri-benhamou-cm537133,"Dr. Pierre-Henri Benhamou co-founded DBV Technologies in 2002, and has served as Chief Executive Officer from 2002 to the present and Chairman of board of directors since initial public offering on NYSE Euronext Paris in March 2012. With Pr. Christophe Dupont and Bertrand Dupont, he described for the first time and"
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies Reveals Positive Data on Viaskin Peanut,2015-10-05 21:03:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/K-XSuBmVMRA/dbv-technologies-reveals-positive-data-on-viaskin-peanut-cm527265,"DBV TechnologiesDBVT announced top line results from the OLFUS study on Viaskin Peanut for the treatment of patients with peanut allergy. The ongoing, open label, follow up study to VIPES (Viaskin Peanut's Efficacy and Safety) demonstrated long term safety"
DBVT,DBVT:UW,BBG0076D3TP5,DBV Technologies Reveals Positive Data on Viaskin Peanut,2015-10-05 18:40:06 +0000,http://finance.yahoo.com/news/dbv-technologies-reveals-positive-data-184006481.html,DBV Technologies Reveals Positive Data on Viaskin Peanut
DBVT,DBVT:UW,BBG0076D3TP5,"DBV's Peanut-Allergy Patch More Effective With Time, Study Finds",2015-10-05 05:00:00 +0000,http://www.bloomberg.com/news/articles/2015-10-05/dbv-s-peanut-allergy-patch-more-effective-with-time-study-finds?cmpid=yhoo,"DBV's Peanut-Allergy Patch More Effective With Time, Study Finds"
DBVT,DBVT:UW,BBG0076D3TP5,European ADRs Climb Driven by Mining & Oil Majors,2015-09-16 18:34:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iOFmFFw-iA0/european-adrs-climb-driven-by-mining-oil-majors-cm520633,"American depository receipts of European stocks were trading 1.22% higher at 132.96 on the Bank of New York Mellon Europe ADR Index on Wednesday. In continental Europe, French biopharmaceutical firm DBV Technologies ( DBVT ) led decliners, sliding 2%,"
DBVT,DBVT:UW,BBG0076D3TP5,"Baker Bros. Relentlessly Adding Shares Of One Biotech, Going Activist On Another",2015-09-16 18:14:06 +0000,http://www.insidermonkey.com/blog/baker-bros-relentlessly-adding-shares-of-one-biotech-going-activist-on-another-371152/,"Baker Bros. Relentlessly Adding Shares Of One Biotech, Going Activist On Another"
DBVT,DBVT:UW,BBG0076D3TP5,"XenoPort, Inc. And DBV Technologies SA: Two Healthcare Stocks With Opposing Momentum",2015-09-15 16:23:57 +0000,http://www.insidermonkey.com/blog/xenoport-inc-and-dbv-technologies-sa-two-healthcare-stocks-with-opposing-momentum-370883/,"XenoPort, Inc. And DBV Technologies SA: Two Healthcare Stocks With Opposing Momentum"
DBVT,DBVT:UW,BBG0076D3TP5,"Go nuts!: Aimmune Therapeutics prices upsized IPO at $16, the high end of the range",2015-08-05 23:59:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9_10UFtViwM/go-nuts-aimmune-therapeutics-prices-upsized-ipo-at-16-the-high-end-of-the-range-cm505658,"Aimmune Therapeutics, which is developing an oral immunotherapy to desensitize peanut allergies, raised $160 million by offering 10 million shares at $16.00, the high end of the range of $14 to $16. Aimmune Therapeutics plans to list on the"
DBVT,DBVT:UW,BBG0076D3TP5,The biotech breakdown on valuation and returns: Large biotechs outperform smaller peers,2015-08-04 23:02:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qDs_a3QtM6s/the-biotech-breakdown-on-valuation-and-returns-large-biotechs-outperform-smaller-peers-cm502052,"Large biotechs outperform those that command smaller valuations at the time of the IPO. Early stage immunotherapy biotech NantKwest ( NK ) priced above the range on Monday night, and its fully diluted market cap of $2.6 billion makes"
DBVT,DBVT:UW,BBG0076D3TP5,Peanut allergy biotech Aimmune Therapeutics sets terms for $125 million IPO,2015-08-01 22:19:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HEbCL2MyXLs/peanut-allergy-biotech-aimmune-therapeutics-sets-terms-for-125-million-ipo-cm501041,"Aimmune Therapeutics, which is developing an oral immunotherapy designed to lessen the effects of peanut allergies, announced terms for its IPO on Monday. The Brisbane, CA based company plans to raise $125 million by offering 8.3 million shares at"
